EDGAR Filing Documents for 0001625101-18-000036

Form 8-K12B - Notification that a class of securities of successor issuer is deemed to be registered pursuant to section 12(b):

SEC Accession No. 0001625101-18-000036

Filing Date

2018-06-18

Accepted

2018-06-18 16:55:10

Documents

Period of Report

2018-06-18

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		plse-20180618x8k.htm	8-K12B	53263
2		plse-20180618xex2_1.htm	EX-2.1	38895
3		plse-20180618xex3_1.htm	EX-3.1	70619
4		plse-20180618xex3_2.htm	EX-3.2	11844
5		plse-20180618xex3_3.htm	EX-3.3	41219
6		plse-20180618xex3_4.htm	EX-3.4	294764
7		plse-20180618xex4_1.htm	EX-4.1	6929
8		plse-20180618xex4_1g001.jpg	GRAPHIC	158132
9		plse-20180618xex4_1g002.jpg	GRAPHIC	76240
10		plse-20180618xex10_1.htm	EX-10.1	121286
	Complete submission text file	0001625101-18-000036.txt		963259

Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545

Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600

Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)